A recent study explores the use of docetaxel for recurrent adult granulosa cell tumor, highlighting its potential to enable tertiary cytoreduction. This research contributes to the understanding of treatment options for this rare tumor type.
docetaxel for recurrent adult granulosa cell tumor enabling tertiary cytoreduction
Original title: “Docetaxel for recurrent adult granulosa cell tumor enabling tertiary cytoreduction.”